The OTC Space | Tag Archive

ISDA AGM 2013 | Virtually There

April 25, 2013 by Bill Hodgson 3 Comments

For the many who couldn’t attend this years ISDA AGM, below is a round up of the key stories. If any of the attendees have anecdotes, incriminating pictures or gossip, please send it over. Best quote of the AGM, courtesy of Risk: Athanassios Diplas, a senior adviser to the Isda board said: “If I tell you […]

ISDA, News

2013, AGM, Annual General Meeting, otc derivatives

Is traditional portfolio management dead?

April 17, 2013 by Tom Riesack 1 Comment

When listening to the presenters on the “Portfolio Optimisation & Quantitative Investment Summit” at the Global Derivatives Trading and Risk Management event in Amsterdam this week one could draw such a conclusion. Another is: “Do not worry!”, because, not least due to the 2008 crisis, risk management models and portfolio construction models have evolved and […]

Conference, derivatives, Diversification, otc derivatives, Risk management

Ever thought swaps trading was a niche market…

April 15, 2013 by Tom Riesack 0 Comments

… well, think again, as the DTCC confirmed a whopping 65,000 entities have been registered and certified via the CFTC Interim Compliant Identifier (CICI) utility until April 10th, the deadline imposed by the CFTC to get such an identifier if you want to continue trading in the swaps market. This number includes market participants from […]

CICI, Depository Trust & Clearing Corporation, Dodd–Frank Wall Street Reform and Consumer Protection Act, DTCC, LEI, otc derivatives, SWIFT

FTT and its impact on corporate and sovereign debt

April 3, 2013 by Maria Leontiou 2 Comments

A new report is out on the Financial Transaction Tax (FTT) and its impact on corporate and sovereign debt, written by London Economics on behalf of the Regulatory Strategy Group (RSG) and sponsored by the City of London. You can either get the pdf here or read a good summary at Securities Finance Monitor. Either way, the conclusion […]

Financial Transaction Tax, FTT, otc derivatives, politics, regulation, regulations, Repo

BaFIN briefing: EMIR II under development

April 1, 2013 by Tom Riesack 2 Comments

Contacts at BaFIN I met last week described negotiations being conducted within the European Parliament, which frankly mean far more work for regulatory compliance, than expected. EMIR II, i.e. a revised and extended version of the European Market Infrastructure Regulation, is already being formulated between the EU Commission under Patrick Pearson, and European Council and […]

Dodd–Frank Wall Street Reform and Consumer Protection Act, EMIR, esma, European Market Infrastructure Regulation, European Securities and Markets Authority, Michel Barnier, otc derivatives, Sharon Bowles, Werner Langen

Börsenzeitung – Clearingpflicht für Derivate verzögert sich bis Ende 2014

March 29, 2013 by Tom Riesack 1 Comment

Nicht wirklich überraschend, aber auch die Börsenzeitung hat nun festgestellt, dass das Clearing von OTC Derivaten in Europa mit einiger Sicherheit erst im Sommer / Frühherbst 2014 in Kraft treten wird. Der Artikel findet sich im Volltext auf der Homepage der Börsenzeitung hier. (Bitte in der Suche “ESMA” eingeben – eine direkte Verlinkung von Arikeln […]

EMIR, ESMA, OTC Derivatives

EMIR, esma, otc derivatives, regulation

Optimizing the Cost of Customization for OTC Derivatives End Users

March 28, 2013 by Jon Skinner 0 Comments

Optimizing the Cost of Customization for OTC Derivatives End Users For those of you who haven’t seen it I recommend the article with the above title in the paper at the attached link (starts on page 69) published by the Institute for Financial Markets and written by Sean Owens from Woodbine Associates (a research-based consulting […]

Basel III, bilateral, cftc, cleared, Initial Margin, o malia, otc, otc derivatives

Size Matters | Naked Capitalism and the $1.2 Quadrillion Question

March 26, 2013 by Bill Hodgson 2 Comments

A blog post over at Naked Capitalism here, alleged the OTC market is now $1.2 Quadrillion in notional value, which was re-posted from another site here, which based it’s numbers on yet another post here written in June 2010. One quote below alleges that the trades on the OTC market have a value of $1.2 quadrillion, when of […]

Credit Risk, notional, otc derivatives, Quadrillion

Have you assessed the impact of OTC regulation on your business?

March 25, 2013 by Maria Leontiou 0 Comments

An interesting analysis by the law firm Jones Day on the potential impact of the U.S. Dodd-Frank Act over at Lexology. As the article puts it, you should first review your OTC derivatives transactions and the identity and regulatory status of your counterparties to determine your exposure to various requirements. This won’t be an easy task due […]

CFTC, Dodd Frank, News

counterparties, otc derivatives, regulatory status